CHARLESTOWN, Mass.--(BUSINESS WIRE)--In 2005, PHT became the first electronic patient reported outcome (ePRO) provider to conduct a clinical trial using electronic patient diaries in Japan. Since then, Japanese sponsors have been able to take advantage of the benefits of PHT’s market-leading LogPad® System, which has been selected for use in over 275 trials worldwide. Today, PHT is excited to announce its partnership with Mebix, Inc., the leading provider of evidence based medicine monitoring solutions in Japan, to further enhance and advance the ePRO experience for Japanese biopharmaceutical companies. With Mebix providing expert localized Sales, Study Support and Project Management services, PHT is strengthening its position as the ePRO vendor of choice in the Asia-Pacific region.
